article thumbnail

Keys to Success in Vaccine Development for Special Populations

PPD

From study participants’ consent, to minimizing the patient and caregiver burden, to planning for different needs at different stages of the pediatric immune system, there are many factors to consider when conducting clinical research with this specific population.

Vaccine 52
article thumbnail

The Chemistry Clicked: Two NIH-Supported Researchers Win 2022 Nobel Prize in Chemistry

NIH Director's Blog: Drug Development

Barry Sharpless, Scripps Research, La Jolla, CA, October 5, 2022 marked the second time that he’s received an early-morning congratulatory call from The Royal Swedish Academy of Sciences. 2001, 40 (11), 2004–2021 [2] A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “Llgation” of azides and terminal alkynes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials

Alta Sciences

Altasciences’ experienced clinical researchers can accommodate and advise you on your pain management and treatment contributions, the needs of your therapeutic studies, how to best utilize various pain models, and evaluate and assess the efficacy of your treatment. billion people that suffer from chronic pain, globally , (51.6

article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

CellProthera selected the UK centres for their excellence in the conduct of clinical research with dedicated staff, equipment, availability of imaging platforms and high interest in cell therapy cardiovascular trials especially University Hospital of Birmingham equipped with a bi-plane Cathlab.

Drugs 189
article thumbnail

Chipscreen and HISUN reach a strategic cooperation

The Pharma Data

SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. Such cooperation will rapidly expand the coverage of the drug product after its launch, providing professional pharmaceutical services to doctors and patients, and benefit more patients.”

article thumbnail

Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the European Union

Conversations in Drug Development Trends

Regulatory Harmonization of Clinical Trials in the EU The EU-CTR repealed the Clinical Trial Directive 2001/20/EC (CTD) and national implementing legislation in the EU Member States on 31 January 2022.

Trials 52
article thumbnail

Where is the promise for plant-based medicines? Part 2: Psilocybin 

Drug Discovery World

Within the debate, an e-petition was presented, which closed in February 2023 and received 11,824 signatures, and called on the government to reschedule psilocybin for medical research on untreatable conditions to Schedule II of the Misuse of Drugs Regulations 2001. million in seed funding, bringing the total to date up to £2.5